Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Berntorp

Showing results (81-90 of 250) with videos related to

Pageof 25
Sort By:
Thrombosis Research|April 27, 2001
Anti- and procoagulant activities in factor VII-deficient subjectsJ Astermark, L Tengborn, U Hedner, et al.
Lakartidningen|August 24, 1994
[Ambulatory treatment without complications. A 1-year experience in distal deep-vein thrombosis]P Svensson, S Lethagen, E Lindén, et al.
Diabetes Research (Edinburgh, Scotland)|May 1, 1987
Lymphocyte transglutaminase function may be impaired in type 2 diabetes mellitusE Berntorp, K Berntorp, B Seiving, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 9, 2015
Association between bleeding tendency and health-related quality of life in carriers of moderate and severe haemophiliaA Olsson, M Hellgren, E Berntorp, et al.
Lakartidningen|February 12, 1998
[Hemophiliacs with HIV. Slower progression of the infection among younger patients and at higher dosages of factor concentrates]J Astermark, E Berntorp, L Stigendal, et al.
Journal of Internal Medicine|December 1, 1995
Effects of low-density lipoprotein apheresis (dextran sulphate adsorption method) on bleeding tendency in treatment patientsC H Florén, E Berntorp, K E Hagstam
European Journal of Haematology|October 1, 1993
Pharmacokinetic dosing in prophylactic treatment of hemophilia AM Carlsson, E Berntorp, S Björkman, et al.
Annual Review of Medicine|January 1, 1997
Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosisB Zöller, A Hillarp, E Berntorp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 2, 2010
Physical activity for prevention of osteoporosis in patients with severe haemophilia on long-term prophylaxisM Khawaji, J Astermark, K Akesson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 1, 1985
[3H]ouabain binding and sodium content in lymphocyte sub-populations and the demonstration of increased binding in type 2 diabetes mellitusE Berntorp, K Berntorp, D Nelson, et al.
Pageof 25

Showing results (81-90 of 250) with videos related to

Sort By:
Pageof 25
Thrombosis Research|April 27, 2001
Anti- and procoagulant activities in factor VII-deficient subjectsJ Astermark, L Tengborn, U Hedner, et al.
Lakartidningen|August 24, 1994
[Ambulatory treatment without complications. A 1-year experience in distal deep-vein thrombosis]P Svensson, S Lethagen, E Lindén, et al.
Diabetes Research (Edinburgh, Scotland)|May 1, 1987
Lymphocyte transglutaminase function may be impaired in type 2 diabetes mellitusE Berntorp, K Berntorp, B Seiving, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 9, 2015
Association between bleeding tendency and health-related quality of life in carriers of moderate and severe haemophiliaA Olsson, M Hellgren, E Berntorp, et al.
Lakartidningen|February 12, 1998
[Hemophiliacs with HIV. Slower progression of the infection among younger patients and at higher dosages of factor concentrates]J Astermark, E Berntorp, L Stigendal, et al.
Journal of Internal Medicine|December 1, 1995
Effects of low-density lipoprotein apheresis (dextran sulphate adsorption method) on bleeding tendency in treatment patientsC H Florén, E Berntorp, K E Hagstam
European Journal of Haematology|October 1, 1993
Pharmacokinetic dosing in prophylactic treatment of hemophilia AM Carlsson, E Berntorp, S Björkman, et al.
Annual Review of Medicine|January 1, 1997
Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosisB Zöller, A Hillarp, E Berntorp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 2, 2010
Physical activity for prevention of osteoporosis in patients with severe haemophilia on long-term prophylaxisM Khawaji, J Astermark, K Akesson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 1, 1985
[3H]ouabain binding and sodium content in lymphocyte sub-populations and the demonstration of increased binding in type 2 diabetes mellitusE Berntorp, K Berntorp, D Nelson, et al.
Pageof 25